TB-500 10mg Research Peptide

TB-500 10mg is a synthetic research peptide designed to mimic Thymosin Beta-4, a naturally occurring protein encoded by the TMSB4X gene. Composed of 43 amino acids, TB-500 is supplied as a lyophilized powder with a reported purity greater than 99% and is intended strictly for laboratory research use. TB-500 10mg is studied in preclinical models for its involvement in cellular migration, cytoskeletal regulation, angiogenesis-related signaling, and tissue repair pathways.

What Is TB-500 10mg?

TB-500 10mg is the laboratory-produced form of Thymosin Beta-4, a protein found naturally in high concentrations within blood platelets and wound fluid. In research settings, TB-500 is used to allow controlled investigation into the biological roles attributed to Thymosin Beta-4, including cellular movement, tissue organization, and regenerative signaling observed in experimental systems.

TB-500 10mg is an experimental research peptide and is not approved for human or animal use.

Research Background

Thymosin Beta-4 has been widely studied in laboratory and animal models for its role in cellular repair and regeneration. TB-500 has been examined as a research analog to explore similar biological pathways under controlled experimental conditions.

Preclinical research involving TB-500 has focused on its potential involvement in:

• Cellular migration and motility models

• Cytoskeletal dynamics and actin regulation

• Angiogenesis-associated signaling pathways

• Tissue organization and remodeling research

These findings remain preclinical and have not been validated in human clinical trials.

Mechanisms of Research Interest

Actin Interaction

TB-500 contains the peptide segment LKKTETQ, identified as a potential actin-binding region. Research suggests this interaction may influence cytoskeletal structure by binding to globular actin (G-actin), a process relevant to cell movement and tissue organization studies.

Actin Sequestration

Experimental models propose that TB-500 may increase the intracellular pool of G-actin by inhibiting the polymerization of filamentous actin (F-actin), which could affect cellular motility and remodeling pathways.

Angiogenesis Research

TB-500 has been investigated for its possible role in biological processes associated with new blood vessel formation, a pathway of interest in wound healing and tissue regeneration research.

Intracellular and Extracellular Activity

Studies have detected Thymosin Beta-4 both inside cells and in plasma. Research involving TB-500 has explored whether it may influence cellular energy regulation and motility through interactions with ATP synthase–related enzymes at the cell surface.

All mechanisms described are experimental observations only and do not imply therapeutic benefit.

Molecular and Chemical Information

• Product Name: TB-500 10mg

• Form: Lyophilized powder

• Purity: Greater than 99%

• Amino Acid Length: 43 residues

• Molecular Formula: C220H350N56O78S

• Molecular Weight: Approximately 4,925 g/mol

• Alternate Names: Thymosin Beta-4, Tβ4

Research Applications

TB-500 10mg may be utilized by qualified researchers in laboratory investigations involving:

• Cytoskeletal and actin-binding studies

• Cellular migration and motility research

• Angiogenesis and tissue organization models

• Regenerative biology and repair signaling pathways

All use must remain within controlled laboratory environments.

Regulatory Status and Use Disclaimer

• For research use only

• Not approved by the Food and Drug Administration

• Not intended for human or veterinary use

• Not intended to diagnose, treat, cure, or prevent any disease

• No established clinical safety, dosing, or efficacy data